# ACPs in Severe PAD/CLI by Direct Intramuscular Injection

> **NCT00523731** · PHASE1 · COMPLETED · sponsor: **TheraVitae Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Critical Limb Ischemia

## Interventions

- **PROCEDURE:** Angiogenic Cell Precursors (ACPs) or Vescell TM

## Key facts

- **NCT ID:** NCT00523731
- **Lead sponsor:** TheraVitae Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2007-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523731, "ACPs in Severe PAD/CLI by Direct Intramuscular Injection". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00523731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*